Yale New Haven failed to notify parents about the use of the cow-based formula, which they expressly asked staff not to use. A judge found that the hospital failed to stock a human alternative, known to be safer for premature newborns. 

The label is the most serious warning the agency can place on pharmaceuticals, denoting substances that carry serious health risks that must be weighed against benefits. CNN was the first to report the news, citing two sources familiar with the matter. 

San Diego-based Vektor Medical first secured FDA clearance for the AI-powered technology back in 2021. This updated announcement covers the latest version, which includes atrial flutter mapping and several other new features.

ASCs have their limitations, but they are also associated with several benefits for cardiologists and patients alike.

These most recent recalls focus on a series of maintenance issues. In 2024, the FDA advised customers to transition away from the two devices and find alternative treatment options.

According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.

According to attorneys representing a potential class action of plaintiffs, Sharp HealthCare was not forthcoming about its use of a tool for automatic note-taking. The technology allegedly captures everything said in an exam room, including sensitive details on diagnoses, and sends it to an offsite server.

In a new data analysis from nine states, the Centers for Disease Control and Prevention found that the protective effect tapers off as juveniles age, with 5-17 year olds seeing fewer trips to urgent care or the emergency room at a rate of 56%. Overall, the agency said evidence shows that COVID-19 vaccines are still effective.